Literature DB >> 3930855

Dihydropyrimidine dehydrogenase deficiency--a further case.

B Wilcken, J Hammond, R Berger, G Wise, C James.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3930855     DOI： 10.1007/bf01811485

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN： 0141-8955            Impact factor:   4.982


× No keyword cloud information.
  4 in total

1.  The activities of thymidine metabolising enzymes during the cell cycle of a human lymphocyte cell line LAZ-007 synchronised by centrifugal elutriation.

Authors:  A A Piper; M H Tattersall; R M Fox
Journal:  Biochim Biophys Acta       Date:  1980-12-15

2.  Urinary excretion of thymine and uracil in a two-year-old child with a malignant tumor of the brain.

Authors:  G Berglund; J Greter; S Lindstedt; G Steen; J Waldenström; U Wass
Journal:  Clin Chem       Date:  1979-07       Impact factor: 8.327

3.  Elevated urine, blood and cerebrospinal fluid levels of uracil and thymine in a child with dihydrothymine dehydrogenase deficiency.

Authors:  J A Bakkeren; R A De Abreu; R C Sengers; F J Gabreëls; J M Maas; W O Renier
Journal:  Clin Chim Acta       Date:  1984-07-31       Impact factor: 3.786

4.  Dihydropyrimidine dehydrogenase deficiency leading to thymine-uraciluria. An inborn error of pyrimidine metabolism.

Authors:  R Berger; S A Stoker-de Vries; S K Wadman; M Duran; F A Beemer; P K de Bree; J J Weits-Binnerts; T J Penders; J K van der Woude
Journal:  Clin Chim Acta       Date:  1984-08-31       Impact factor: 3.786
  4 in total
  6 in total

1.  A new case of dihydropyrimidine dehydrogenase deficiency.

Authors:  M Brockstedt; C Jakobs; L M Smit; A H van Gennip; R Berger
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

2.  Dihydropyrimidine dehydrogenase deficiency presenting at birth.

Authors:  N A Al-Sanna'a; A B P Van Kuilenburg; T M Atrak; M A Abdul-Jabbar; A H Van Gennip
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

3.  Physiologically based pharmacokinetic modelling of the three-step metabolism of pyrimidine using C-uracil as an in vivo probe.

Authors:  Suminobu Ito; Takeshi Kawamura; Makoto Inada; Yoshiharu Inoue; Yukihiro Hirao; Toshihisa Koga; Jun-ichi Kunizaki; Takefumi Shimizu; Hitoshi Sato
Journal:  Br J Clin Pharmacol       Date:  2005-12       Impact factor: 4.335

4.  Clinical variability in three Danish patients with dihydropyrimidine dehydrogenase deficiency all homozygous for the same mutation.

Authors:  E Christensen; I Cezanne; S Kjaergaard; H Hørlyk; V Faurholt Pedersen; P Vreken; A B van Kuilenburg; A H Van Gennip
Journal:  J Inherit Metab Dis       Date:  1998-06       Impact factor: 4.982

Review 5.  Inborn errors of pyrimidine degradation: clinical, biochemical and molecular aspects.

Authors:  A H van Gennip; N G Abeling; P Vreken; A B van Kuilenburg
Journal:  J Inherit Metab Dis       Date:  1997-06       Impact factor: 4.982

6.  Phenotypic profiling of DPYD variations relevant to 5-fluorouracil sensitivity using real-time cellular analysis and in vitro measurement of enzyme activity.

Authors:  Steven M Offer; Natalie J Wegner; Croix Fossum; Kangsheng Wang; Robert B Diasio
Journal:  Cancer Res       Date:  2013-01-17       Impact factor: 12.701
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.